CEBINA Announces Positive Results of a Phase 2 Clinical Study with COVID-19 clients and Azelastine Nasal Spray Published in a Peer-Reviewed Scientific Journal
May 2, 2023 CEBINA GmbH Vienna, Austria - 02.05.2003 -- CEBINA GmbH, Central European Biotech Incubator and Accelerator, today announces…